mRESIST aims to implement a model of analysis in order to move forward in understanding resistant schizophrenia.
m-Resist is a research & innovation project funded by the EU under the Horizon 2020 program in the domain of PHC-26-2014: Self-management of health and disease: citizen engagement and mHealth. The project started 1st of January 2015 and will run for a period of thirty-six months. The primary objective of the mResist project is to develop a therapeutic program that draws on the support of mobile devices to actively involve patients with treatment-resistant schizophrenia, to make them capable of self-managing their own illness, as well as to support their careers.
No front page content has been created yet.
See the latest news of mResist project…
m-RESIST was presented in the last
On 7th, 8th & 9th of June 2016, the EC co-funded project m-RESIST had its 4th Plenary Meeting in Oulu.
In the context of the Mobile World Congress 2016 in Barcelona, Spain, took place the event
Check out the first newsletter of m-RESIST project to stay alert on the project's developments, news and progress made!
m-RESIST Poster “What do we know about treatment resistant schizophrenia? - A systematic review” has been presented by BSc, med.
Several sensors are currently available with smart watches, bracelets, smartphones and technology devices in general.
The three clinical partners of the m-RESIST group have been working on a document to identify and compare available health care resources in Israel, Hungary and
At the end of May 2015, users’ focus groups were performed in the three countries involved (Spain, Hungary and Israel). This activity was led by Parc Sanitari
m-RESIST Oral Poster, “An innovative and integrative m-Health solution for treatment resistant schizophrenia patients” will be presented by MSc Anna Alonso (S
m-RESIST will be presented during the Symposium “Lifespan development of schizophrenia and how the treatments improve outcome”, chaired by Professor emeritus
m-RESIST Poster “m-RESIST, an Integrative M-Health Solution for Treatment-Resistant Schizophrenia According to User’ needs: Focus Groups Findings” will be
On 27th & 28th of January 2016, the EC co-funded project m-RESIST had its 3rd Plenary Meeting in Tel Aviv.
On 2 June and 3 June 2015, the EC co-funded project m-RESIST had its 2nd Plenary Meeting in Barcelona.
Meet some of our project partners from the kick-off meeting who tell us more about their expectations of the m-RESIST project.
Consortium has submitted mResist’s presentation to Euro Global Summit and Medicare Expo on Psychiatry